Montag & Associates’s Hinge Health HNGE Stock Holding History

Montag & Associates’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-800	Closed	-$41.4K	–	1161
2025 Q2	$41.4K	Buy	+800	New	+$32.3K	﹤0.01%	606

Other funds holding HNGE

IHG

Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Montag & Associates's HNGE Position: Q3 2025 in Review

Montag & Associates sold out of Hinge Health (HNGE) in Q3 2025, closing a stake of 800 shares — an estimated $41.4K sold.

Montag & Associates first reported a position in HNGE in Q2 2025 and held it in 1 quarter. The position peaked at $41.4K in Q2 2025. 146 funds tracked by Wall St. Rank hold HNGE as of Q3 2025.

Montag & Associates reported no remaining Hinge Health position as of Q3 2025 after selling out during the quarter.
Montag & Associates sold 800 Hinge Health shares in Q3 2025, an estimated $41.4K.
Montag & Associates first reported a position in Hinge Health in Q2 2025 and held it in 1 quarter.
Montag & Associates's Hinge Health position peaked at $41.4K in Q2 2025.
146 funds tracked by Wall St. Rank held Hinge Health as of Q3 2025.

Based on Montag & Associates's 13F filing for Q3 2025, filed 12 Nov 2025.